Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands ...
Explore casino cybersecurity in 2026: top threats, real-world attacks, and best practices to protect players, payments, and ...
GenAI isn’t magic — it’s transformers using attention to understand context at scale. Knowing how they work will help CIOs ...
Educators and state legislators across the nation are pushing to banish smartphones from the classroom as evidence mounts ...
Edge devices across multiple applications share common attack vectors. Security functionality must be designed in from the ...
New regulations make this non-negotiable, but multi-die assemblies and more interactions at the edge are creating some huge ...
Digital IDs in mobile wallets are reducing friction at checkout and verification, helping retailers reconnect online ...
Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...
Positive $60,000, down from $2 million in the prior-year period. Gross margin -- 43%, down from 50% last year due to ...
Google Gemini may perform competency very convincingly, but if you use it for everything, you may end up dealing with wrong ...
Amid the current debate over the devastating impact of recent aid cuts on global health programmes, the question of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback